These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38414082)

  • 1. Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.
    Lee CH; Banoei MM; Ansari M; Cheng MP; Lamontagne F; Griesdale D; Lasry DE; Demir K; Dhingra V; Tran KC; Lee T; Burns K; Sweet D; Marshall J; Slutsky A; Murthy S; Singer J; Patrick DM; Lee TC; Boyd JH; Walley KR; Fowler R; Haljan G; Vinh DC; Mcgeer A; Maslove D; Mann P; Donohoe K; Hernandez G; Rocheleau G; Trahtemberg U; Kumar A; Lou M; Dos Santos C; Baker A; Russell JA; Winston BW;
    Crit Care; 2024 Feb; 28(1):63. PubMed ID: 38414082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform.
    Ferrarini A; Righetti L; Martínez MP; Fernández-López M; Mastrangelo A; Horcajada JP; Betbesé A; Esteban A; Ordóñez J; Gea J; Cabello JR; Pellati F; Lorente JA; Nin N; Rupérez FJ
    Electrophoresis; 2017 Sep; 38(18):2341-2348. PubMed ID: 28714069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study.
    Fanelli V; Giani M; Grasselli G; Mojoli F; Martucci G; Grazioli L; Alessandri F; Mongodi S; Sales G; Montrucchio G; Pizzi C; Richiardi L; Lorini L; Arcadipane A; Pesenti A; Foti G; Patroniti N; Brazzi L; Ranieri V
    Crit Care; 2022 Feb; 26(1):34. PubMed ID: 35123562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
    Bal A; Casalegno JS; Melenotte C; Daviet F; Ninove L; Edouard S; Morfin F; Valette M; De Lamballerie X; Lina B; Papazian L; Nougairède A; Hraiech S
    Clin Microbiol Infect; 2020 Jul; 26(7):947.e1-947.e4. PubMed ID: 32205296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
    Lorente JA; Nin N; Villa P; Vasco D; Miguel-Coello AB; Rodriguez I; Herrero R; Peñuelas O; Ruiz-Cabello J; Izquierdo-Garcia JL
    Crit Care; 2021 Nov; 25(1):390. PubMed ID: 34781986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.
    Smith V; Devane D; Nichol A; Roche D
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013819. PubMed ID: 33348427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia.
    Izquierdo-Garcia JL; Nin N; Jimenez-Clemente J; Horcajada JP; Arenas-Miras MDM; Gea J; Esteban A; Ruiz-Cabello J; Lorente JA
    Shock; 2018 Nov; 50(5):504-510. PubMed ID: 29293175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation for the treatment of ARDS in Covid-19 and influenza patients: Does etiology matter?
    Kotarski V; Santini M; Krajinović V; Papić N; Gjurašin B; Krznarić J; Kutleša M
    Int J Artif Organs; 2022 Jul; 45(7):647-651. PubMed ID: 35435028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course.
    Töpfer L; Menk M; Weber-Carstens S; Spies C; Wernecke KD; Uhrig A; Lojewski C; Jörres A; Deja M
    J Crit Care; 2014 Jun; 29(3):340-6. PubMed ID: 24508203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal membrane oxygenation for COVID-19 and influenza associated acute respiratory distress syndrome: a systematic review.
    Wang L; Wang D; Zhang T; He Y; Fan H; Zhang Y
    Expert Rev Respir Med; 2023; 17(10):951-959. PubMed ID: 37847592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units.
    Li SH; Hsieh MJ; Lin SW; Chuang LP; Lee CS; Chiu LC; Chang CH; Hu HC; Huang CC; Kao KC
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):26-33. PubMed ID: 30852002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.
    ; Davies A; Jones D; Bailey M; Beca J; Bellomo R; Blackwell N; Forrest P; Gattas D; Granger E; Herkes R; Jackson A; McGuinness S; Nair P; Pellegrino V; Pettilä V; Plunkett B; Pye R; Torzillo P; Webb S; Wilson M; Ziegenfuss M
    JAMA; 2009 Nov; 302(17):1888-95. PubMed ID: 19822628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome.
    Brun-Buisson C; Richard JC; Mercat A; Thiébaut AC; Brochard L;
    Am J Respir Crit Care Med; 2011 May; 183(9):1200-6. PubMed ID: 21471082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ARDS and influenza A (H1N1): patients' characteristics and management in intensive care unit. A literature review].
    Jaber S; Conseil M; Coisel Y; Jung B; Chanques G
    Ann Fr Anesth Reanim; 2010 Feb; 29(2):117-25. PubMed ID: 20116970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Critical Care Occupancy and Outcomes of Critically Ill Patients during the 2020 COVID-19 Winter Surge and 2009 H1N1 Influenza Pandemic in Australia.
    Serpa Neto A; Burrell AJC; Bailey M; Broadley T; Cooper DJ; French CJ; Pilcher D; Plummer MP; Trapani T; Webb SA; Bellomo R; Udy A
    Ann Am Thorac Soc; 2021 Aug; 18(8):1380-1389. PubMed ID: 33356988
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study.
    Maamar A; Liard C; Doucet W; Reizine F; Painvin B; Delamaire F; Coirier V; Quelven Q; Guillot P; Lesouhaitier M; Tadié JM; Gacouin A
    Virol J; 2022 Sep; 19(1):145. PubMed ID: 36085163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.
    Tang X; Du RH; Wang R; Cao TZ; Guan LL; Yang CQ; Zhu Q; Hu M; Li XY; Li Y; Liang LR; Tong ZH; Sun B; Peng P; Shi HZ
    Chest; 2020 Jul; 158(1):195-205. PubMed ID: 32224074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia.
    Banoei MM; Vogel HJ; Weljie AM; Kumar A; Yende S; Angus DC; Winston BW;
    Crit Care; 2017 Apr; 21(1):97. PubMed ID: 28424077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of survivors with influenza A H1N1 virus-induced severe pneumonia and ARDS: a single-center prospective cohort study.
    Tang X; Xu XL; Wan N; Zhao Y; Wang R; Li XY; Li Y; Wang L; Li HC; Gu Y; Zhang CY; Yang Q; Tong ZH; Sun B
    Front Cell Infect Microbiol; 2024; 14():1378379. PubMed ID: 38606295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.